Inhibikase Therapeutics (IKT) Announces FDA Clinical Hold on IkT-148009 Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. AAPL
4. SPGI
5. USO
6. DELL
7. ENOV
8. AON
9. NIO
10. EIX

Go back to Inhibikase Therapeutics (IKT) Announces FDA Clinical Hold on IkT-148009 Programs
(NASDAQ: IKT) Delayed: 2.38 +0.07 (3.03%)
Previous Close $2.31    52 Week High $ 
Open $2.30    52 Week Low $ 
Day High $2.41    P/E N/A 
Day Low $2.27    EPS $ 
Volume 523,237